CVE-2026-77124Nexus Repository 3 - Script Execution Disable Setting Not Enforced
Updated under an hour ago ()
Does this affect you?
It affects Sonatype Nexus Repository 3. Add what you run to find out whether that includes you.
No exploitation reported and no EPSS estimate yet.
Do this next
Free account, 1 product
In affected versions of Nexus Repository 3, the script execution endpoint (POST /service/rest/v1/script/{name}/run) did not verify whether script execution had been administratively disabled. An account holding script-execution permission could continue to run previously-created scripts even after an administrator set nexus.scripts.allowCreation=false, undermining the expectation that this setting fully blocks script execution.
- CVSS
- 7.5 HIGH (v4.0, CNA)CVSS:4.0/AV:N/AC:L/AT:P/PR:H/UI:N/VC:H/VI:H/VA:H/SC:N/SI:N/SA:N
- Weakness (CWE)
- CWE-184
- Known exploited
- Not in CISA's KEV catalog
- EPSS (exploitation in the next 30 days)
- Not loaded for this CVE
- Assigned by
- Sonatype
- NVD analysis
- Analyzed
- Record last updated
- Sep 2, 2026
- First seen by InfoSec Signals
- Oct 9, 2026
Affected products
Sonatype Nexus Repository 3 sonatype:nexus_repository_manager | from 3.21.2 before 3.96.0 | CNA record |
sonatype nexus_repository_manager sonatype:nexus_repository_manager | from 3.21.2 before 3.96.0 | NVD |
References
- https://help.sonatype.com/en/sonatype-nexus-repository-3-96-0-release-notes.htmlpatch, release-notes
- https://support.sonatype.com/hc/en-us/articles/54641528273811/vendor-advisory, mitigation
The CVE record on cve.org NVD's entry
The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.